CareDx (CDNA)
(Real Time Quote from BATS)
$8.05 USD
-0.18 (-2.19%)
Updated Apr 24, 2024 11:54 AM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Income Statements
Fiscal Year end for CareDx, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 280 | 322 | 296 | 192 | 127 |
Cost Of Goods | 102 | 112 | 97 | 63 | 45 |
Gross Profit | 178 | 210 | 199 | 129 | 82 |
Selling & Adminstrative & Depr. & Amort Expenses | 382 | 287 | 229 | 152 | 106 |
Income After Depreciation & Amortization | -203 | -77 | -30 | -23 | -25 |
Non-Operating Income | 13 | 1 | -2 | 3 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | -1 |
Pretax Income | -190 | -76 | -32 | -20 | -24 |
Income Taxes | 0 | 0 | -1 | -1 | -2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -190 | -77 | -31 | -19 | -22 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -190 | -77 | -31 | -19 | -22 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -188 | -61 | -17 | -13 | -19 |
Depreciation & Amortization (Cash Flow) | 15 | 16 | 13 | 10 | 6 |
Income After Depreciation & Amortization | -203 | -77 | -30 | -23 | -25 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 53.77 | 53.32 | 52.24 | 46.48 | 42.15 |
Diluted EPS Before Non-Recurring Items | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 |
Diluted Net EPS (GAAP) | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 |
Fiscal Year end for CareDx, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 65.57 | 67.19 | 70.30 | 77.26 |
Cost Of Goods | NA | 25.61 | 24.53 | 25.89 | 25.97 |
Gross Profit | NA | 39.96 | 42.66 | 44.41 | 51.30 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 66.29 | 71.44 | 72.04 | 75.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -26.33 | -28.78 | -27.63 | -24.32 |
Non-Operating Income | NA | 4.70 | 5.22 | 2.60 | 0.70 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -117.93 | -23.57 | -25.02 | -23.63 |
Income Taxes | NA | 0.17 | -0.08 | -0.07 | 0.12 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -118.10 | -23.49 | -24.95 | -23.75 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -118.10 | -23.49 | -24.95 | -23.75 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 53.39 | 54.18 | 53.85 | 53.64 |
Diluted EPS Before Non-Recurring Items | NA | -2.21 | -0.43 | -0.46 | -0.44 |
Diluted Net EPS (GAAP) | NA | -2.21 | -0.43 | -0.46 | -0.44 |